Last Updated on May 15, 2024 by The Health Master
Download: Drugs Act – Notifications
The Govt. of India issues notifications from time to time, which are published by the Department of Publication and printed regularly by the Government of India Printing Presses.
We have provided some of the notifications relevant to the above-said topic, Click on the below links for more information:
2024
S.O. 1577(E) dt 28-03-2024 Implementation of Jan Vishwas (Amendment of Provisions) Act, 2023 related to Provisions of D & C Act
S.O. 567(E) dt 06-02-2024 Appointment of Shri Arijit Saha and Shri Turjya Ray as Govt Analyst at CDTL Indore – Drugs and Cosmetics Act 1940
2023
S.O. 4351(E) dt 05-10-2023 Notification of Shri Pankaj P Thakur Government Analyst CDTL MUMBAI
S.O. 627(E) dt 08-02-2023 Government Analyst Notification Dr Raghuram Reddy, Shri K Nitin Kumar for CDTL Hyderabad
2022
S.O. 5090(E) dt 02-11-2022 Appointment of Smt. G Sasikala, Shri Kishore, Smt. Rimjhim as Govt Analyst at CDTL Chennai – Drugs and Cosmetics Act 1940
S.O. 3758(E) dt 10-08-2022 To authorize director incharge Dr. Saroj Kumar Ghosh of CDL Kolkata for signing report of test of MD samples sent by Court of Laws.
S.O. 3757(E) dt 10-08-2022 Notification of Director Incharge Dr Saroj Kumar Ghosh of CDL Kolkata
S.O. 3739(E) dt 02-08-2022 Notification of Medical Devices Testing Officer for CMDTL
Ministry of Health Dt 08-07-2022 Draft of New Drugs, Medical Devices, and Cosmetics Bill 2022
Ministry-of-Health-Dt-08-07-2022-Draft-of-New-Drugs-Medical-Devices-and-Cosmetics-Bill-2022
2021
S.O. 5139(E) dt 10-12-2021 Renotification of NIB Noida as CDL for testing of COVID 19 vaccine Section 6 and 26 B of Drugs and Cosmetics Act
GSR 767(E) dt 27-10-2021 Draft – to amend rule 2 to substitute cell or stem cell-derived product under New Drugs and Clinical Trial Rules 2019
GSR 762(E) dt 27-10-2021 – Sec 10 of D&C Act – To allow the import of Oxytocin API for the manufacture of formulation for export purpose only
S.O. 4326(E) dt 18-10-2021 – Section 5 of D&C Act Reconstitution of DTAB
GSR 668(E) dt 23-09-2021 – Draft Amendment addition of Homoeopathic System in the First Schedule of D&C Act
S.O. 1521(E) dt 08-04-2021 Notification of 5 officers at CDTL, Mumbai as Government Analysts under section 20(2) of the Drugs and Cosmetics Act, 1940
S.O. 1520(E) dt 07-04-2021 Notification of officer at CDTL, Hyderabad as Government Analyst under section 20(2) of the Drugs and Cosmetics Act, 1940
GSR 255(E) dt 07-04-2021 Exclusion of FDC of Tamsulosin and Deflazacort from banned list of drugs
S.O.1260(E) dt 19-03-2021 Notification of Debasis Maitti and Hitesh Khare as Govt. Analysts at RDTL Chandigarh
S.O. 1170(E) dt 12-03-2021 Notification Amar jyoti, Dilip Kr, Rinku & Arun Kr at RDTL Guwahati as Govt. analyst
2020
S.O. 2451 (E) dt 20-07-2020 – Sec 26B – Exemption of sale license for sanitizers
GSR-No-220 (E) dt. 26-03-2020 Regarding door step delivery of medicine
GSR-219 (E) dt 26-03-2020 Regarding Hydroxychloroquine is Schedule-H 1 drug now
G.S.R.-52 (E) dt. 27-01-2020 Exemption of Import of Oxytocin reference standards from Prohibition
2019
S.O. 4671(E) dt. 27-12-2019 Effective date – notification as drug Nebulizer, Blood Pressure Monitoring Devices, Digital Thermometer, Glucometer
GSR 4271(E) dt 26-11-2019 – 12 Govt Analyst notified for the whole of India
G.S.R. No. 827 (E) dt. 06-11-19 Draft Notification Sch-K
S.-O.-1500 (E) dt. 02-04-2019 Organ preservative solution as drug
2018
S.O. 5980(E) dt. 03-12-2018 notification as drug Nebulizer, Blood Pressure Monitoring Devices, Digital Thermometer, Glucometer
GSR 794(E) dt 21-08-2018 Mfg of Oxytocin Formulation by Public Sector 26A of D&C Act
S.O.-3400-E-dt.-11-07-18-Medical-devices-MDTO
GSR 411(E) dt 27.04.2018 – Manufacture Prohibition of Oxytocin with conditions under Section 26A of D&C Act
GSR 390(E) dated 24.04.2018 Import banning of Oxytocin under Section 10A D&C Act
2015
GSR 2393(E) dt 02-09-2015 – 5 Govt Analyst notified for the whole of India
2012
S.O. 2809(E) dt 30-11-2012 Appointment of Smt. C Vijaya, Smt. J Uma as Govt Analyst at CDTL Chennai – Drugs and Cosmetics Act 1940
S.O. 2808(E) dt 30-11-2012 Appointment of Smt. Mansi, Smt. Sayati as Govt Analyst at CDTL Mumbai – Drugs and Cosmetics Act 1940
2011
GSR 2213(E) dt 26-09-2011 – 2 Govt Analyst notified for the whole of India in NIB Noida
S.O. 722(E) dt 08-04-2011 – Section 5 – Constitution of DTAB – Drugs and Cosmetics Act
2009
GSR 738(E) dt 09-10-2009 Amendment in the notification number G.S.R. 578(E), 23rd July, 1983 Substitutes FDC of Corticosteroid with any other drug for internal use
2008
Drugs and Cosmetics (Amendment) Act No. 26 of 2008
Drugs-and-Cosmetics-Amendment-Act-No.-26-of-2008
For Drugs Rules notifications, click here
For more Notifications on the following topics, click the below links:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
